Year: 2024 | Month: January-March | Volume: 9 | Issue: 1 | Pages: 87-96
DOI: https://doi.org/10.52403/gijhsr.20240109
Description of Urea and Creatinine Levels in Dyspepsia Patients Taking Proton Pump Inhibitor Drugs at the Indonesian Christian University Hospital in 2018
Nur Nunu Prihantini1, Christian Ronald Tanggo2
1Department of Biochemistry, Faculty of Medicine, Universitas Kristen Indonesia, Jakarta, Indonesia
2Department of Surgery, Faculty of Medicine, Faculty of Medicine, Universitas Kristen Indonesia, Jakarta, Indonesia
Corresponding Author: Nur Nunu Prihantini
ABSTRACT
Dyspepsia is a health problem often encountered by doctors in daily practice. Many people complain of symptoms of dyspepsia but do not seek help for treatment. Proton pump inhibitors are the drugs for the treatment of dyspepsia, such as omeprazol, lansoprazol, esomeprazol, rabeprazol, and pantoprazol. Some studies have explained that proton pump inhibitor drugs can interfere with kidney function due to acute interstitial nephritis due to the consumption of proton pump inhibitors, and this condition can end with chronic kidney disease that occurs due to undiagnosed acute interstitial nephritis. This study aimed to see how urea and creatinine levels in dyspepsia patients at Universitas Kristen Indonesia Hospital were taking proton pump inhibitors. This research is a descriptive research content analysis, hospital-based. Based on medical records at Universitas Kristen Indonesia Hospital in 2018, 80.3% high ureum levels and 19.7% normal ureum levels were found. In creatinine levels, it was found that men had more normal creatinine levels of 57.7% and high ureum levels of 42.3%, and women found more normal creatinine levels of 62.5% and high creatinine levels of 37.5%.
Keywords: Dyspepsia, Proton Pump Inhibitor, Creatinine, Ureum